Engineering Immunity: The Future of mRNA Technology and Respiratory Vaccines

Engineering Immunity: The Future of mRNA Technology and Respiratory Vaccines

From Let’s Talk Lungs Podcast by Lung Sask

May 6, 2026 · 29 min · Episode 20

About this episode

Dr. Kyle Brown discusses the future of mRNA technology and its implications for respiratory vaccines.

Join Lung Saskatchewan’s Let’s Talk Lungs hosts Trent and Lori for a timely conversation with Dr. Kyle Brown, Associate Director, Field Medical Advisor, Moderna Canada. mRNA technology has already changed the game, and its potential in respiratory health is still unfolding. In this episode, Dr. Brown will unpack what’s on the horizon: how mRNA platforms are evolving, what that could mean for the next generation of respiratory vaccines, and where the most exciting innovation may be headed. Dr. Brown brings expertise in Medical Affairs & Medical Information and a deep background in infectious disease, vaccine development (human & animal), molecular biology, and mRNA technology. He earned his B.Sc. and Ph.D. in Medical Microbiology from the University of Manitoba and completed post-doctoral research with VIDO at the University of Saskatchewan. This episode is sponsored by Moderna Canada.

People in this episode

Hosts: Trent, Lori

Guest: Dr. Kyle Brown

Topics covered

  • mRNA technology
  • respiratory vaccines
  • infectious disease
  • vaccine development
  • medical affairs
  • molecular biology

Keywords

  • mRNA
  • respiratory health
  • vaccines
  • Moderna
  • infectious disease
  • medical microbiology
  • vaccine innovation

Sponsors

Moderna Canada

Mentioned in this episode

Organizations: Lung Saskatchewan, University of Manitoba, VIDO, University of Saskatchewan

More episodes of Let’s Talk Lungs Podcast

Explore listener stats, chart rankings, contacts and more on the Let’s Talk Lungs Podcast podcast page.